Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

M Annala; G Lo; R Aggarwal; EJ Small; M Nykter; ME Gleave; KN Chi; AW Wyatt; WJ Struss; EW Warner; K Beja; G Vandekerkhove; A Wong; D Khalaf; IL Seppälä; A So

doi:10.1016/j.eururo.2017.02.023

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

M Annala, G Lo, R Aggarwal, EJ Small, M Nykter, ME Gleave, KN Chi, AW Wyatt, WJ Struss, EW Warner, K Beja, G Vandekerkhove, A Wong, D Khalaf, IL Seppälä, A So

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

187 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	34-42
Julkaisu	European Urology
Vuosikerta	72
Numero	1
DOI - pysyväislinkit	https://doi.org/10.1016/j.eururo.2017.02.023
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

Abiraterone
BRCA2
Castration-resistant prostate cancer
Cell-free DNA
Circulating tumor DNA
DNA repair
Enzalutamide
Liquid biopsy

Julkaisufoorumi-taso

Jufo-taso 3

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1016/j.eururo.2017.02.023

Siteeraa tätä

Annala, M., Lo, G., Aggarwal, R., Small, EJ., Nykter, M., Gleave, ME., Chi, KN., Wyatt, AW., Struss, WJ., Warner, EW., Beja, K., Vandekerkhove, G., Wong, A., Khalaf, D., Seppälä, IL., & So, A. (2017). Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer. European Urology, 72(1), 34-42. https://doi.org/10.1016/j.eururo.2017.02.023

@article{40fbda59f3c3453da2e7bc5d3d12887e,

title = "Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer",

keywords = "Abiraterone, BRCA2, Castration-resistant prostate cancer, Cell-free DNA, Circulating tumor DNA, DNA repair, Enzalutamide, Liquid biopsy, Abiraterone, BRCA2, Castration-resistant prostate cancer, Cell-free DNA, Circulating tumor DNA, DNA repair, Enzalutamide, Liquid biopsy",

author = "M Annala and G Lo and R Aggarwal and EJ Small and M Nykter and ME Gleave and KN Chi and AW Wyatt and WJ Struss and EW Warner and K Beja and G Vandekerkhove and A Wong and D Khalaf and IL Sepp{\"a}l{\"a} and A So",

year = "2017",

doi = "10.1016/j.eururo.2017.02.023",

language = "English",

volume = "72",

pages = "34--42",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

Annala, M, Lo, G, Aggarwal, R, Small, EJ, Nykter, M, Gleave, ME, Chi, KN, Wyatt, AW, Struss, WJ, Warner, EW, Beja, K, Vandekerkhove, G, Wong, A, Khalaf, D, Seppälä, IL & So, A 2017, 'Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer', European Urology, Vuosikerta 72, Nro 1, Sivut 34-42. https://doi.org/10.1016/j.eururo.2017.02.023

TY - JOUR

T1 - Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

AU - Annala, M

AU - Lo, G

AU - Aggarwal, R

AU - Small, EJ

AU - Nykter, M

AU - Gleave, ME

AU - Chi, KN

AU - Wyatt, AW

AU - Struss, WJ

AU - Warner, EW

AU - Beja, K

AU - Vandekerkhove, G

AU - Wong, A

AU - Khalaf, D

AU - Seppälä, IL

AU - So, A

PY - 2017

Y1 - 2017

KW - Abiraterone

KW - BRCA2

KW - Castration-resistant prostate cancer

KW - Cell-free DNA

KW - Circulating tumor DNA

KW - DNA repair

KW - Enzalutamide

KW - Liquid biopsy

KW - Abiraterone

KW - BRCA2

KW - Castration-resistant prostate cancer

KW - Cell-free DNA

KW - Circulating tumor DNA

KW - DNA repair

KW - Enzalutamide

KW - Liquid biopsy

U2 - 10.1016/j.eururo.2017.02.023

DO - 10.1016/j.eururo.2017.02.023

M3 - Article

SN - 0302-2838

VL - 72

SP - 34

EP - 42

JO - European Urology

JF - European Urology

IS - 1

ER -